Campbell & CO Investment Adviser LLC Astrazeneca PLC Transaction History
Campbell & CO Investment Adviser LLC
- $1.53 Billion
- Q2 2025
A detailed history of Campbell & CO Investment Adviser LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 34,430 shares of AZN stock, worth $2.59 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
34,430
Previous 57,767
40.4%
Holding current value
$2.59 Million
Previous $4.25 Million
43.35%
% of portfolio
0.16%
Previous 0.33%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,413Shares Held
506MCall Options Held
9.17MPut Options Held
3.07M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.3 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.68 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...